Identification of systemic markers from a pulmonary carbon nanotube exposure

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 6 SUPPL., 2011, Pages

  Erdely, Aaron ^a,b   Liston, Angie ^a   Salmen Muniz, Rebecca ^a,b   Hulderman, Tracy ^a,b   Young, Shih Houng ^b   Zeidler Erdely, Patti C ^b   Castranova, Vincent ^b   Simeonova, Petia P ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CARBON NANOTUBE; COMPLEMENT COMPONENT C3; CYTOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PLASMA PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; EOSINOPHIL; FEMALE; GENE EXPRESSION; IMMUNE FUNCTION TEST; LUNG LAVAGE; MALE; MOUSE; NASOPHARYNGEAL ASPIRATION; NONHUMAN; PROTEOMICS;

MUS;

EID: 79959240186     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31821ad724     Document Type: Article

References (68)

1. Brook RD, Rajagopalan S, Pope CA III, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331-2378.
2. Araujo JA, Barajas B, Kleinman M, et al. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res. 2008;102:589-596. (Pubitemid 351416760)
3. Li Z, Hulderman T, Salmen R, et al. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ Health Perspect. 2007;115:377-382. (Pubitemid 46554435)
4. Nemmar A, Hoet PH, Vandervoort P, et al. Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet-leukocyte activation: role of P-selectin. J Thromb Haemost. 2007;5:1217-1226. (Pubitemid 46902124)
5. Mitchell LA, Gao J, Wal RV, et al. Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci. 2007;100:203-214. (Pubitemid 47617817)
6. Mitchell LA, Lauer FT, Burchiel SW, McDonald JD. Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat Nanotechnol. 2009;4:451-456.
7. Erdely A, Hulderman T, Salmen R, et al. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett. 2009;9:36-43.
8. Lam CW, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of singlewall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci. 2004;77:126-134. (Pubitemid 38128652)
9. Mangum JB, Turpin EA, Antao-Menezes A, Cesta MF, Bermudez E, Bonner JC. Single-walled carbon nanotube (SWCNT)-induced interstitial fibrosis in the lungs of rats is associated with increased levels of PDGF mRNA and the formation of unique intercellular carbon structures that bridge alveolar macrophages in situ. Part Fibre Toxicol. 2006;3:15.
10. Mercer RR, Scabilloni J, Wang L, et al. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am J Physiol Lung Cell Mol Physiol. 2008;294:L87-97.
11. Muller J, Huaux F, Moreau N, et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol. 2005;207:221-231. (Pubitemid 41207915)
12. Porter DW, Hubbs AF, Mercer RR, et al. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology. 2010;269:136-147.
13. Shvedova AA, Kisin ER, Mercer R, et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes inmice. Am J Physiol Lung Cell Mol Physiol. 2005;289:L698-708.
14. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GA, Webb TR. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci. 2004;77:117-125. (Pubitemid 38128651)
15. Trout DB, Schulte PA. Medical surveillance, exposure registries, and epidemiologic research for workers exposed to nanomaterials. Toxicology. 2010;269:128-135.
16. Howard J, Murashov V. National nanotechnology partnership to protect workers. J Nanopart Res. 2009;11:1673-1683.
17. Rao GV, Tinkle S, Weissman DN, et al. Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J Toxicol Environ Health A. 2003;66:1441-1452. (Pubitemid 36976208)
18. Zeidler-Erdely PC, Kashon ML, Battelli LA, et al. Pulmonary inflammation and tumor induction in lung tumor susceptible A/J and resistant C57BL/6J mice exposed to welding fume. Part Fibre Toxicol. 2008;5:12.
19. Stevens WW, Kim TS, Pujanauski LM, Hao X, Braciale TJ. Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry. J Immunol Methods. 2007;327:63-74. (Pubitemid 47444310)
20. Song X, Bandow J, Sherman J, et al. iTRAQ experimental design for plasma biomarker discovery. J Proteome Res. 2008;7:2952-2958.
21. Vaughan DE. PAI-1 and atherothrombosis. J Thromb Haemost. 2005;3:1879-1883. (Pubitemid 41716575)
22. Bigert C, Alderling M, Svartengren M, Plato N, de Faire U, Gustavsson P. Blood markers of inflammation and coagulation and exposure to airborne particles in employees in the Stockholm underground. Occup Environ Med. 2008;65:655-658.
23. Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS. The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults. Am J Respir Crit Care Med. 2007;176:370-376.
24. Mills NL, Tornqvist H, Robinson SD, et al. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 2005;112:3930-3936. (Pubitemid 43739491)
25. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta. 2000;1477:267-283. (Pubitemid 30119906)
26. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.
27. Hobeika MJ, Thompson RW, Muhs BE, Brooks PC, Gagne PJ. Matrix metalloproteinases in peripheral vascular disease. J Vasc Surg. 2007;45:849-857. (Pubitemid 46483940)
28. Holven KB, Halvorsen B, Bjerkeli V, et al. Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects. Stroke. 2006;37:1731-1736. (Pubitemid 44297721)
29. Sundstrom J, Evans JC, Benjamin EJ, Levy D, Larson MG, et al. Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study. Circulation. 2004;109:2850-2856. (Pubitemid 38786446)
30. Sundstrom J, Evans JC, Benjamin EJ, et al. Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographicmeasures: the Framingham heart study. Eur Heart J. 2004;25:1509-1516. (Pubitemid 39165629)
31. Wilson EM, Gunasinghe HR, Coker ML, et al. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail. 2002;8:390-398. (Pubitemid 36055741)
32. Inoue K, Koike E, Yanagisawa R, Hirano S, Nishikawa M, Takano H. Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. Toxicol Appl Pharmacol. 2009;237:306-316.
33. Inoue K, Yanagisawa R, Koike E, Nishikawa M, Takano H. Repeated pulmonary exposure to single-walled carbon nanotubes exacerbates allergic inflammation of the airway: possible role of oxidative stress. Free Radic Biol Med. 2010;48:924-934.
34. Nygaard UC, Hansen JS, Samuelsen M, Alberg T, Marioara CD, Løvik M. Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice. Toxicol Sci. 2009;109:113-123.
35. Han JH, Lee EJ, Lee JH, et al. Monitoring multiwalled carbon nanotube exposure in carbon nanotube research facility. Inhal Toxicol. 2008;20:741-749. (Pubitemid 351882937)
36. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143. (Pubitemid 34212626)
37. Kido T, Tamagawa E, Bai N, et al. Particulatematter induces IL-6 translocation from the lung to the systemic circulation. Am J Respir Cell Mol Biol. 2010.
38. Mutlu GM, Green D, Bellmeyer A, et al. Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin Invest. 2007;117:2952-2961. (Pubitemid 47529625)
39. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002;106:1439-1441.
40. Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913-919. (Pubitemid 34925323)
41. Wang X, Chai H, Wang Z, Lin PH, Yao Q, Chen C. Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol. 2008;295:H2399-H2408.
42. Costa DL, Dreher KL. Bioavailable transition metals in particulate matter mediate cardiopulmonary injury in healthy and compromised animal models. Environ Health Perspect. 1997;105(suppl 5):1053-1060.
43. Dreher KL, Jaskot RH, Lehmann JR, Richards JH, McGee JK, et al. Soluble transition metals mediate residual oil fly ash induced acute lung injury. J Toxicol Environ Health. 1997;50:285-305.
44. Gavett SH, Madison SL, Dreher KL, et al. Metal and sulfate composition of residual oil fly ash determines airway hyperreactivity and lung injury in rats. Environ Res. 1997;72:162-172. (Pubitemid 27176085)
45. Sehlstedt M, Behndig AF, Boman C, Blomberg A, Sandstrom T, Pourazar J. Airway inflammatory response to diesel exhaust generated at urban cycle running conditions. Inhal Toxicol. 2010;22:1144-1150.
46. Walters DM, Breysse PN, Wills-Karp M. Ambient urban Baltimore particulate-induced airway hyperresponsiveness and inflammation in mice. Am J Respir Crit Care Med. 2001;164:1438-1443. (Pubitemid 33124023)
47. Haegens A, Barrett TF, Gell J, et al. Airway epithelial NF-kappaB activation modulates asbestos-induced inflammation and mucin production in vivo. J Immunol. 2007;178:1800-1808. (Pubitemid 46154652)
48. Levis J, Loi R, Butnor KJ, et al. Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant. Am J Respir Cell Mol Biol. 2008;38:16-25.
49. Walsh ER, August A Eosinophils and allergic airway disease: there is more to the story. Trends Immunol. 2010;31:39-44.
50. Dollery CM, McEwan JR, Wang M, Sang QA, Liu YE, Shi YE. TIMP-4 is regulated by vascular injury in rats. Circ Res. 1999;84:498-504. (Pubitemid 29138586)
51. Koskivirta I, Rahkonen O, Mayranpaa M, et al. Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology. Histochem Cell Biol. 2006;126:335-342.
52. Hamad I, Christy Hunter A, Rutt KJ, Liu Z, Dai H, Moein Moghimi S. Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover. Mol Immunol. 2008;45:3797-3803.
53. Salvador-Morales C, Flahaut E, Sim E, Sloan J, Green ML, Sim RB. Complement activation and protein adsorption by carbon nanotubes. Mol Immunol. 2006;43:193-201. (Pubitemid 41384125)
54. Hadnagy W, Stiller-Winkler R, Idel H. Immunological alterations in sera of persons living in areas with different air pollution. Toxicol Lett. 1996;88:147-153. (Pubitemid 26361260)
55. Shima M, Adachi M, Tanaka T, Tsunetoshi Y. Serum complement levels in children in communities with different levels of air pollution in Japan. Arch Environ Health. 1999;54:264-270. (Pubitemid 29344876)
56. Stiller-Winkler R, Kramer U, Fiedler E, Ewers U, Dolgner R. C3c concentrations in sera of persons living in areas with different levels of air pollution in Northrhine-Westphalia (Federal Republic of Germany). Environ Res. 1989;49:7-19. (Pubitemid 19147041)
57. Engstrom G, Hedblad B, Berglund G, Janzon L, Lindgarde F. Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study. J Hum Hypertens. 2007;21:276-282. (Pubitemid 46443589)
58. Engstrom G, Hedblad B, Eriksson KF, Janzon L, Lindgarde F. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes. 2005;54:570-575.
59. Theroux P, Martel C. Complement activity and pharmacological inhibition in cardiovascular disease. Can J Cardiol. 2006;22(suppl B):18B-24B.
60. Kramer U, Herder C, Sugiri D, et al. Traffic-related air pollution and incident type 2 diabetes: results from the SALIA cohort study. Environ Health Perspect. 2010.
61. Furlaneto CJ, Ribeiro FP, Hatanaka E, Souza GM, Cassatella MA, Campa A. Apolipoproteins A-I and A-II downregulate neutrophil functions. Lipids. 2002;37:925-928.
62. Hamilton KK, Zhao J, Sims PJ. Interaction between apolipoproteins A-I and A-II and the membrane attack complex of complement: affinity of the apoproteins for polymeric C9. J Biol Chem. 1993;268:3632-3638. (Pubitemid 23071007)
63. Hyka N, Dayer JM, Modoux C, et al. Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood. 2001;97:2381-2389. (Pubitemid 32291485)
64. Clifton PM, Mackinnon AM, Barter PJ. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. J Lipid Res. 1985;26:1389-1398. (Pubitemid 16189736)
65. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest. 1996;26:427-435. (Pubitemid 26226404)
66. Ruppert C, Bagheri A, Markart P, Schmidt R, Seeger W, Günther A. Liver carboxylesterase cleaves surfactant protein (SP-) B and promotes surfactant subtype conversion. Biochem Biophys Res Commun. 2006;348:1449-1454. (Pubitemid 44291360)
67. Armstrong PB. Proteases and protease inhibitors: a balance of activities in host-pathogen interaction. Immunobiology. 2006;211:263-281.
68. Craig-Barnes HA, Doumouras BS, Palaniyar N. Surfactant protein D interacts with alpha2-macroglobulin and increases its innate immune potential. J Biol Chem. 2010;285:13461-13470.